Federal Circuit Affirms That Composition of Matter Claims are Directed to Patentable Subject Matter

The U.S. Court of Appeals for the Federal Circuit (CAFC) reversed the decision of the U.S. International Trade Commission (ITC) that certain “composition of matter” claims granted to US Synthetic were directed to a patent ineligible abstract idea under 35 U.S.C. § 101. US Synthetic Corp. v. International Trade Commission, No. 23-1217 (Fed. Cir. February [...]

By |2025-08-27T16:10:13+00:00August, 2025|Governments|0 Comments

Federal Circuit Affirms that Medical Devices are Only Listable in the Orange Book if They Claim the Active Drug Ingredient

In the AIPLA Spring 2025 newsletter, Nath, Goldberg & Meyer ‘s Joshua Goldberg and Leia Dingott discuss how Court of Appeals for the Federal Circuit (CAFC) affirmed the decision by the U.S. District Court in New Jersey, which ordered the delisting of five U.S. Patents owned by TEVA on the ground “that the Inhaler Patents [...]

By |2025-05-08T14:23:15+00:00May, 2025|Governments|0 Comments
Go to Top